Back

IMUNON says committee recommends continued Phase 2 development of IMNN-001

Verifying
  • IMUNON reported a recommendation to continue IMNN-001’s Phase 2 development.
  • IMNN-001’s safety review received a favorable assessment from the monitoring committee.
  • The recommendation came from an Independent Data Monitoring Committee after its review.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.